Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Stock analysts at Zacks Research increased their FY2024 earnings estimates for shares of Immunovant in a research note issued on Thursday, April 25th. Zacks Research analyst E. Bagri now expects that the company will post earnings of ($1.72) per share for the year, up from their prior forecast […]
Kovack Advisors Inc. grew its stake in BlackRock MuniVest Fund II, Inc. (NYSE:MVT – Free Report) by 6.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 24,324 shares of the financial services provider’s stock after acquiring an additional 1,516 shares during the quarter. […]
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) insider Julia G. Butchko sold 10,115 shares of the business’s stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $29.06, for a total value of $293,941.90. Following the completion of the transaction, the insider now directly owns 451,627 shares in […]
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Stock analysts at Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for Immunovant in a research note issued on Monday, April 8th. Zacks Research analyst E. Bagri now anticipates that the company will post earnings per share of ($0.49) for the quarter, down from their […]
BlackRock MuniVest Fund II, Inc. (NYSE:MVT – Get Free Report) announced a monthly dividend on Monday, April 1st, Wall Street Journal reports. Stockholders of record on Monday, April 15th will be paid a dividend of 0.0505 per share by the financial services provider on Wednesday, May 1st. This represents a $0.61 dividend on an annualized […]